🔗 Share this article

A shadow economy for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Material Removal

Based on the social media company, the platform has removed problematic material and banned associated hashtags and search suggestions. The organization stated it was committed to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at home.

Within moments of joining one community, a vendor shared WhatsApp details, where the majority of transactions occur. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Item Information and Pricing

Within these communities, posts display dark colored packages with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients injured by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational product not yet approved … may subject patients to possibly serious medical dangers”.